ArticleCancers2020

Real Life Prospective Evaluation of New Drug-Eluting Platform for Chemoembolization of Patients with Hepatocellular Carcinoma: PARIS Registry.

Thierry de Baere et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.